Dr. Fran Brown, SVP of Drug Development Science at Certara, joins this episode of CertaraTalks to share highlights from J.P. Morgan’s BiotechShowcase 2024. Watch below for insights and key takeaways around topics like the current funding environment, the role of generative AI in the regulatory processes, and advancements in cancer medicine. Transcript: Hello. I’m doctor … Continued
Join us in this episode of CertaraTalks as Roman Casciano and Ananth Kadambi discuss the key highlights from ISPOR Europe 2023. Watch below for insights and key takeaways around topics like the European health data space and the use of AI for health technology assessment. Transcript Hello, and welcome to Certara Talks. I’m Doctor Suzanne … Continued
The latest episode of CertaraTalks features Dr. Mirjam Trame and Dr. Piet van der Graaf being interviewed by Dr. Suzanne Minton on the key moments from the annual meeting of the American Conference on Pharmacometrics, ACoP14! Explore highlights ranging from the dynamic ISOP Trainee Communications Challenge to the groundbreaking use of ArtificialIntelligence in Quantitative Systems … Continued
In the latest CertaraTalks episode, Krista K. Greenwood, PhD, DABT, Director of Toxicology at Certara, shares key insights from the American College of Toxicology 2023 Annual Meeting. Explore highlights like Project Optimus, the FDA’s groundbreaking dose optimization initiative for oncology products, and updates on the latest safety pharmacology best practices. Transcript: Introduction Welcome. You’re watching … Continued
Laura Sheppard joins this episode of #CertaraTalks to share highlights from #AMWA2023. Watch below for insights and key takeaways around topics like AI and the evolution of technology in medical writing and the importance of plain language summaries. Video Transcript: Hello, everybody. I’m Doctor. Suzanne Minton. I’m a director of content strategy at Sartara, and … Continued
In Europe, there are at least as many reimbursement assessment processes in place as European countries. Some of these are transparent and clearly defined like the German AMNOG process, others are even more complex and sometimes even unclear, dependent also on the product of interest. Anyhow, the European Commission has already decided that a European … Continued
R&D World editors Paul Heney and Aimee Kalnoskas have their minds blown — multiple times! — in this episode, which delves into Certara’s Simcyp COVID-19 Vaccine Model, a 2021 R&D 100 Awards winner. Paul interviews Piet van der Graaf, Senior Vice President and Head of Quantitative Systems Pharmacology for Certara and learns about the genesis … Continued
In this episode, Max Williamson, a Patient Representative for the UK National Cancer Research Institute, and Karen Rowland Yeo, PhD, Senior Vice President at Certara, discuss the challenges in pediatric drug development, including accessibility issues for young people and the need for more qualitative data. Max and Karen also talk about how technology can accelerate … Continued
